• HOME
  • Business
  • Stock
  • Property
  • Market
  • Economy
  • Crypto
Language:
×
  • Home
  • tags Apitoria Pharma

Apitoria Pharma News

Business

Aurobindo Pharma's Hyderabad API Unit Faces USFDA Inspection with Two Observations

Ryan Peterson 18 Dec, 2024

Aurobindo Pharma reports that the USFDA inspected its subsidiary Apitoria Pharma's API manufacturing facility in Hyderabad with two procedural observations, to be addressed within ...

Popular News

  • Economy

    North American Spirits Industry Calls for Dialogue Amid Rising US Tariffs

    03 Feb, 2025
  • Economy

    Japan's Prime Minister Ishiba Advocates for Zero Tariffs in US Trade Deal, Eyes Economic Benefits

    11 May, 2025
  • Market

    Vietnam's Stock Market Shows Mixed Signals as Key Indices Experience Fluctuations

    05 May, 2025
  • Business

    Exploring Sharda School of Law's Innovative Approach to Bridging Legal Theory and Practice

    13 May, 2025
  • Business

    Johnson & Johnson Reports Stellar Q2 Growth: Sales Surge 5.8% to $23.7 Billion, Beating Expectations

    17 Jul, 2025
  • Market

    US Stock Markets Surge as Trump's Trade Deals with Japan and EU Boost Investor Confidence

    24 Jul, 2025
  • Market

    US Stock Markets Show Resilience: A Closer Look at the Latest Economic Reports and Disney's Strategic Move

    07 Jan, 2025
  • Business

    Moderna's Shares Dive 19%: A Closer Look at the 2025 Revenue Forecast Adjustment

    13 Jan, 2025

Newsletter

Subscribe Newsletter!

Stay ahead of the market – subscribe now for the latest insights and expert analysis delivered straight to your inbox!

About Us

  • EconWatcher.com is a comprehensive financial website dedicated to providing insights into economics, stocks, real estate, cryptocurrencies, markets, and business trends.
  • 15 Cliff St, New York NY 10038, USA
  • +91 234 567 8765
  • [email protected]

Popular Categories

  • Business (1M+)
  • Stock (1M+)
  • Property (1M+)
  • Market (1M+)
  • Economy (1M+)
  • Crypto (1M+)

Legal

  • Privacy Policy

  • Terms & Conditions

  • Contact Us

Copyright © 2022 All Rights Reserved.